Literature DB >> 15921384

Lack of correlation between iron overload cardiac dysfunction and needle liver biopsy iron concentration.

Vasili Berdoukas, Carolyn Dakin, Anthony Freema, Ian Fraser, Athanassios Aessopos, Timothy Bohane.   

Abstract

In 58 patients with transfusion dependent anemia, we compared cardiac function, as assessed by gated pooled cardiac scan at rest and during exercise stress, with liver iron concentrations (LIC) as determined by adequate biopsy samples. There was no relationship between LIC and cardiac function and deaths occurred in patients with LIC levels below those that are usually associated with cardiac death. LIC should not be used as a surrogate to determine risk of cardiac complications but purely for management of the hepatic iron load. Other methods, particularly magnetic resonance imaging, should be used to assess cardiac iron overload.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15921384

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  11 in total

Review 1.  Early detection of cardiac involvement in thalassemia: From bench to bedside perspective.

Authors:  Nut Koonrungsesomboon; Siriporn C Chattipakorn; Suthat Fucharoen; Nipon Chattipakorn
Journal:  World J Cardiol       Date:  2013-08-26

Review 2.  How I treat Diamond-Blackfan anemia.

Authors:  Adrianna Vlachos; Ellen Muir
Journal:  Blood       Date:  2010-07-22       Impact factor: 22.113

Review 3.  Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity.

Authors:  Suree Lekawanvijit; Nipon Chattipakorn
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

4.  Longitudinal analysis of heart and liver iron in thalassemia major.

Authors:  Leila J Noetzli; Susan M Carson; Anne S Nord; Thomas D Coates; John C Wood
Journal:  Blood       Date:  2008-07-23       Impact factor: 22.113

5.  Heart Rate Variability as an Alternative Indicator for Identifying Cardiac Iron Status in Non-Transfusion Dependent Thalassemia Patients.

Authors:  Karn Wijarnpreecha; Natthaphat Siri-Angkul; Krekwit Shinlapawittayatorn; Pimlak Charoenkwan; Suchaya Silvilairat; Chate Siwasomboon; Pannee Visarutratna; Somdet Srichairatanakool; Adisak Tantiworawit; Arintaya Phrommintikul; Siriporn C Chattipakorn; Nipon Chattipakorn
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

6.  The efficacy of iron chelator regimes in reducing cardiac and hepatic iron in patients with thalassaemia major: a clinical observational study.

Authors:  Vasilios Berdoukas; Giorgos Chouliaras; Panagiotis Moraitis; Kirykos Zannikos; Eleni Berdoussi; Vassilios Ladis
Journal:  J Cardiovasc Magn Reson       Date:  2009-06-28       Impact factor: 5.364

7.  Prevention of cardiomyopathy in transfusion-dependent homozygous thalassaemia today and the role of cardiac magnetic resonance imaging.

Authors:  Athanassios Aessopos; Vasilios Berdoukas; Maria Tsironi
Journal:  Adv Hematol       Date:  2009-04-29

8.  Treating thalassemia major-related iron overload: the role of deferiprone.

Authors:  Vasilios Berdoukas; Kallistheni Farmaki; Susan Carson; John Wood; Thomas Coates
Journal:  J Blood Med       Date:  2012-10-19

Review 9.  The heart in transfusion dependent homozygous thalassaemia today--prediction, prevention and management.

Authors:  Athanassios Aessopos; Vasilios Berdoukas; Maria Tsironi
Journal:  Eur J Haematol       Date:  2007-12-10       Impact factor: 2.997

10.  Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance.

Authors:  Bernadette Modell; Maren Khan; Matthew Darlison; Mark A Westwood; David Ingram; Dudley J Pennell
Journal:  J Cardiovasc Magn Reson       Date:  2008-09-25       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.